Single ascending dose study with SLV354

• Research type

  Research Study

• Full title

  A double-blind, randomized, placebo-controlled single ascending dose study to assess the safety, tolerability, pharmacokinetic and pharmacodynamic profiles of SLV354 after oral dose administration in healthy adult male subjects

• IRAS ID

  40284

• Contact name

  Marianne Kasti

• Contact email

  marianne.kasti@quintiles.com

• Sponsor organisation

  Solvey Pharmaceuticals B.V.

• Eudract number

  2009-017008-10

• ISRCTN Number

  N/A

• Research summary

  no research summary on application form - unable to publish on website

• REC name

  London - Surrey Borders Research Ethics Committee

• REC reference

  09/H0806/77

• Date of REC Opinion

  11 Mar 2010

• REC opinion

  Further Information Favourable Opinion